Dependence of LV Hemodynamics on Pacing Site

This study is currently recruiting participants. (see Contacts and Locations)
Verified September 2015 by St. Jude Medical
Sponsor:
Information provided by (Responsible Party):
St. Jude Medical
ClinicalTrials.gov Identifier:
NCT01564173
First received: March 24, 2012
Last updated: September 10, 2015
Last verified: September 2015

March 24, 2012
September 10, 2015
June 2012
May 2016   (final data collection date for primary outcome measure)
Invasive Dp/dt Max [ Time Frame: Acute E.P. Procedure ] [ Designated as safety issue: No ]
Variation on invasive Dp/dt max during dedicated pacing site
Not Provided
Complete list of historical versions of study NCT01564173 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Dependence of LV Hemodynamics on Pacing Site
Characterization of LV Hemodynamics During Epicardial and Endocardial Pacing
The purpose of this study is to evaluate the effects of epicardial and endocardial pacing at each side of the left ventricular (LV) segments on cardiac hemodynamics in patients with impaired LV function undergoing epicardial ablation and mapping procedure. Hemodynamic function will be assessed during a pacing protocol with a pressure catheter inserted in the LV.
Not Provided
Observational
Observational Model: Case-Only
Time Perspective: Cross-Sectional
Not Provided
Not Provided
Non-Probability Sample
Patients indicated for epicardial mapping and ablation of arrhythmia(s) utilizing a transcutaneous subxiphoid approach
Heart Failure
Not Provided
VT Ablation
Patients undergoing epicardial mapping and ablation procedure for a ventricular tachycardia
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
40
May 2016
May 2016   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Patient is already indicated for epicardial mapping and ablation of arrhythmia(s) utilizing a transcutaneous subxiphoid approach
  • Be in sinus rhythm
  • Have LVEF < 40%
  • Have the ability to provide informed consent for study participation and be willing and able to comply with the CIP (Clinical Investigational Plan) described evaluations

Exclusion Criteria:

  • Have permanent AF
  • Have pericardial disease
  • Have a recent myocardial infarction within 40 days prior to enrollment
  • Have undergone cardiac surgery or coronary revascularization procedure within 3 months prior to enrollment or be scheduled for such procedures
  • Have had a recent CVA or TIA within 3 months prior to enrollment
  • Be less than 18 years of age
  • Be pregnant
Both
18 Years and older
No
France
 
NCT01564173
644
Yes
Not Provided
Not Provided
St. Jude Medical
St. Jude Medical
Not Provided
Principal Investigator: Pierre Jais, MD University Hospital, Bordeaux
St. Jude Medical
September 2015

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP